Donepezil in the treatment of narcolepsy

Journal of Clinical Sleep Medicine

Volumn 2, Issue 1, 2006, Pages 71-72

  Niederhofer, Helmut ^a  

^a CENTRAL HOSPITAL OF BOLZANO   (Italy)

Author keywords

Acetylcholinesterase inhibitors; Donepezil; Narcolepsy

Indexed keywords

DONEPEZIL;

ADULT; ARTICLE; CASE REPORT; CLINICAL FEATURE; FAMILY HISTORY; FEMALE; HUMAN; NARCOLEPSY; NEUROLOGIC EXAMINATION; POLYSOMNOGRAPHY; SCORING SYSTEM; SOMNOLENCE;

EID: 33644657957     PISSN: 15509389     EISSN: 15509397     Source Type: Journal    
DOI: 10.5664/jcsm.26438     Document Type: Article

References (5)

1. Beusterien KM, Rogers AE, Walsleben JA, et al. Health-related quality of life effects of modafinil for treatment of narcolepsy. Sleep 1999;22:757-65.
2. Chakravorty SS, Rye DB. Narcolepsy in the older adult: epidemiology, diagnosis and management. Drugs Aging 2003;20:361-76.
3. Mignot E, Lammers GJ, Ripley B, et al. The role of cerebrospinal fluid hypocretin measurement in the diagnosis of narcolepsy and other hypersomnias. Arch Neurol 2002;59:1553-62.
4. Reid MS, Siegel JM, Dement WC, Mignot E. Cholinergic mechanisms in canine narcolepsy. II. Acetylcholine release in the pontine reticular formation is enhanced during cataplexy. Neuroscience 1994;59:523-30.
5. Vittoz NM, Berridge CW. Hypocretin/orexin selectively increases dopamine efflux within the prefrontal cortex: involvement of the ventral tegmental area. Neuropsychopharmacology 2005;29:1147-53.